Total Visits

Views
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer98

Select a period of time:

Views

Views
November 20252
December 20250
January 20262
February 20260
March 20266
April 20268
May 20267
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
Turkey2
Colombia2
Chile1
United Kingdom1
Guatemala1
Libya1
Mali1
Mexico1
Peru1
 

Top cities views

Views
Los Angeles4
Bogotá2
Ankara1
Bamako1
Guatemala City1
Iztacalco1
Konya1
Mobile1
Moche1
San Jose1